Om

Korsana Biosciences, Inc. is a biotechnology company focused on developing therapies for neurodegenerative diseases, with an initial emphasis on Alzheimer’s disease. Its work centers on THETA, a proprietary blood-brain barrier shuttle platform designed to improve delivery of large therapeutic molecules into the central nervous system. The company’s current pipeline includes THETA-enabled antibody programs aimed at addressing disease biology in the brain, including an anti-amyloid beta approach for Alzheimer’s disease. Korsana Biosciences operates in the health care and life sciences sector, where its role is to advance precision-engineered biologics for central nervous system disorders. The company is based in Waltham, Massachusetts.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I KORSANA BIOSCIENCES MED ENDAVU: Køb Korsana Biosciences ($KRSA) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Korsana Biosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.